Biological Inputs for Life Sciences: Animal Blood & Components Market Dynamics, Serum Products, and
公開 2026/03/27 17:51
最終更新
-
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Animal Blood & Components - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Animal Blood & Components market, including market size, share, demand, industry development status, and forecasts for the next few years.
For biotechnology companies, pharmaceutical manufacturers, and research institutions, the development and production of cell-based therapies, vaccines, and biologics depend critically on high-quality biological raw materials. Animal blood and its components—including serum, plasma, and blood cells—serve as essential inputs for cell culture, diagnostic reagents, and research applications, providing the growth factors, proteins, and nutrients necessary for cellular growth and function. The consistency, safety, and bioactivity of these materials directly impact research outcomes, product quality, and regulatory compliance. Animal blood & components encompass the fluid tissue composed of plasma and blood cells, including serum (fetal bovine serum, bovine calf serum), plasma fractions, and specialized blood products used across medical research, industrial applications, and scientific research. The global market for animal blood & components was valued at US$ 1,638 million in 2025 and is projected to grow at a CAGR of 6.7% to reach US$ 2,562 million by 2032, driven by expanding biopharmaceutical manufacturing, growth in cell and gene therapy development, and increasing demand for cell culture reagents in research and production. In 2024, global production reached approximately 1,867 kiloliters, with an average selling price of US$ 872 per liter.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6097274/animal-blood---components
Market Definition and Product Segmentation
Animal blood & components represent a foundational category within the bioprocessing and life sciences materials market, distinguished by their biological origin and essential role in cell culture, diagnostics, and research. These products include whole blood, plasma, serum, and purified blood components derived from various animal species, with applications ranging from cell culture media supplementation to diagnostic reagent development.
Species Type Segmentation
The market is stratified by source animal, each offering distinct properties and applications:
Bovine: The dominant segment, encompassing fetal bovine serum (FBS), bovine calf serum, and bovine plasma. Bovine-derived products are the most widely used cell culture supplements due to their well-characterized growth factor profiles, availability, and established regulatory acceptance.
Equine: Serving specialized cell culture applications and diagnostic reagent production where horse serum provides specific growth characteristics.
Sheep: Used in veterinary diagnostics, vaccine production, and specialized cell culture applications.
Canine, Feline, and Others: Serving veterinary diagnostics, specialty research, and diagnostic reagent development for species-specific applications.
Camelid: A niche segment supporting specialized research and diagnostic applications.
Application Segmentation
The market serves critical life science sectors:
Medical Research: The largest segment, encompassing cell culture for drug discovery, disease modeling, and basic research requiring serum and blood components as growth media supplements.
Scientific Research: Supporting academic and government research institutions conducting cell biology, immunology, and molecular biology studies.
Industrial Applications: Including vaccine manufacturing, biopharmaceutical production, and diagnostic reagent manufacturing where serum and blood components are essential raw materials.
Other: Including veterinary diagnostics and specialized applications.
Competitive Landscape
The animal blood & components market features a competitive landscape combining global life science leaders with specialized biological materials suppliers. Key players include Thermo Fisher Scientific, Moregate BioTech, GeminiBio, Tissue Culture Biologicals, Bovogen Biologicals (ANZCO Foods Healthcare), Biowest (BioNordic A/S), Internegocios, RMBIO, Biological Industries, Pel-Freez, LLC, Cytiva, HemoStat Laboratories, CellSera Australia, Auckland BioSciences, Animal Technologies, Serana Europe, Peak Serum, Kraeber & Co. GmbH, Lake Immunogenics, Agro-Bio, Bio Nutrientes Do Brasil Ltda., Lanzhou Minhai, Zhejiang Tianhang Biotechnology Co., Ltd., Guangzhou Ruite Biotechnology Co., Ltd., Obio Technology (Shanghai) Corp., Ltd., and MoreCare, Inc.
Industry Development Characteristics
1. Biopharmaceutical Manufacturing Growth
A case study from QYResearch's industry monitoring reveals that the expansion of biopharmaceutical manufacturing—particularly monoclonal antibodies, recombinant proteins, and cell-based therapies—has driven sustained demand for cell culture reagents. Fetal bovine serum and other blood components remain essential supplements for cell culture media in both research and production settings.
2. Cell and Gene Therapy Development
The growth of cell and gene therapy development has increased demand for high-quality, well-characterized serum products. A case study from the cell therapy sector indicates that consistent, lot-to-lot quality is critical for regulatory compliance and product consistency, driving demand for premium, traceable blood components.
3. Vaccine Manufacturing
Vaccine production—including viral vaccines, cell culture-based influenza vaccines, and novel vaccine platforms—requires serum and blood components for cell culture systems. A case study from the vaccine industry indicates that animal blood components are essential raw materials with established regulatory pathways.
4. Raw Material Sourcing and Traceability
Quality and traceability are critical factors in the animal blood & components market. A case study from the regulatory compliance sector indicates that manufacturers with documented supply chains, veterinary oversight, and validated collection and processing protocols capture premium positioning in regulated biopharmaceutical applications.
Exclusive Industry Insights: The Fetal Bovine Serum Dynamics
Our proprietary analysis identifies fetal bovine serum (FBS) as the highest-value and most closely watched segment within the animal blood & components market. FBS is the preferred cell culture supplement due to its high growth factor content and low immunoglobulin levels. However, supply constraints, ethical considerations, and price volatility have driven interest in serum alternatives and defined media. Manufacturers that ensure sustainable sourcing, consistent quality, and supply chain transparency capture competitive advantage in this critical raw material segment.
Strategic Outlook
For industry executives, investors, and marketing leaders evaluating opportunities in the animal blood & components market, the projected 6.7% CAGR reflects sustained demand from biopharmaceutical manufacturing, cell and gene therapy development, and life sciences research. Manufacturers positioned to capture disproportionate share share three characteristics: demonstrated expertise in animal blood collection, processing, and quality control; product portfolios spanning multiple species and component types; and established relationships with biopharmaceutical manufacturers, research institutions, and diagnostic companies. As the market evolves toward defined, animal-free alternatives and enhanced traceability requirements, the ability to deliver consistent, high-quality, and sustainably sourced blood components will define competitive leadership.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
For biotechnology companies, pharmaceutical manufacturers, and research institutions, the development and production of cell-based therapies, vaccines, and biologics depend critically on high-quality biological raw materials. Animal blood and its components—including serum, plasma, and blood cells—serve as essential inputs for cell culture, diagnostic reagents, and research applications, providing the growth factors, proteins, and nutrients necessary for cellular growth and function. The consistency, safety, and bioactivity of these materials directly impact research outcomes, product quality, and regulatory compliance. Animal blood & components encompass the fluid tissue composed of plasma and blood cells, including serum (fetal bovine serum, bovine calf serum), plasma fractions, and specialized blood products used across medical research, industrial applications, and scientific research. The global market for animal blood & components was valued at US$ 1,638 million in 2025 and is projected to grow at a CAGR of 6.7% to reach US$ 2,562 million by 2032, driven by expanding biopharmaceutical manufacturing, growth in cell and gene therapy development, and increasing demand for cell culture reagents in research and production. In 2024, global production reached approximately 1,867 kiloliters, with an average selling price of US$ 872 per liter.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6097274/animal-blood---components
Market Definition and Product Segmentation
Animal blood & components represent a foundational category within the bioprocessing and life sciences materials market, distinguished by their biological origin and essential role in cell culture, diagnostics, and research. These products include whole blood, plasma, serum, and purified blood components derived from various animal species, with applications ranging from cell culture media supplementation to diagnostic reagent development.
Species Type Segmentation
The market is stratified by source animal, each offering distinct properties and applications:
Bovine: The dominant segment, encompassing fetal bovine serum (FBS), bovine calf serum, and bovine plasma. Bovine-derived products are the most widely used cell culture supplements due to their well-characterized growth factor profiles, availability, and established regulatory acceptance.
Equine: Serving specialized cell culture applications and diagnostic reagent production where horse serum provides specific growth characteristics.
Sheep: Used in veterinary diagnostics, vaccine production, and specialized cell culture applications.
Canine, Feline, and Others: Serving veterinary diagnostics, specialty research, and diagnostic reagent development for species-specific applications.
Camelid: A niche segment supporting specialized research and diagnostic applications.
Application Segmentation
The market serves critical life science sectors:
Medical Research: The largest segment, encompassing cell culture for drug discovery, disease modeling, and basic research requiring serum and blood components as growth media supplements.
Scientific Research: Supporting academic and government research institutions conducting cell biology, immunology, and molecular biology studies.
Industrial Applications: Including vaccine manufacturing, biopharmaceutical production, and diagnostic reagent manufacturing where serum and blood components are essential raw materials.
Other: Including veterinary diagnostics and specialized applications.
Competitive Landscape
The animal blood & components market features a competitive landscape combining global life science leaders with specialized biological materials suppliers. Key players include Thermo Fisher Scientific, Moregate BioTech, GeminiBio, Tissue Culture Biologicals, Bovogen Biologicals (ANZCO Foods Healthcare), Biowest (BioNordic A/S), Internegocios, RMBIO, Biological Industries, Pel-Freez, LLC, Cytiva, HemoStat Laboratories, CellSera Australia, Auckland BioSciences, Animal Technologies, Serana Europe, Peak Serum, Kraeber & Co. GmbH, Lake Immunogenics, Agro-Bio, Bio Nutrientes Do Brasil Ltda., Lanzhou Minhai, Zhejiang Tianhang Biotechnology Co., Ltd., Guangzhou Ruite Biotechnology Co., Ltd., Obio Technology (Shanghai) Corp., Ltd., and MoreCare, Inc.
Industry Development Characteristics
1. Biopharmaceutical Manufacturing Growth
A case study from QYResearch's industry monitoring reveals that the expansion of biopharmaceutical manufacturing—particularly monoclonal antibodies, recombinant proteins, and cell-based therapies—has driven sustained demand for cell culture reagents. Fetal bovine serum and other blood components remain essential supplements for cell culture media in both research and production settings.
2. Cell and Gene Therapy Development
The growth of cell and gene therapy development has increased demand for high-quality, well-characterized serum products. A case study from the cell therapy sector indicates that consistent, lot-to-lot quality is critical for regulatory compliance and product consistency, driving demand for premium, traceable blood components.
3. Vaccine Manufacturing
Vaccine production—including viral vaccines, cell culture-based influenza vaccines, and novel vaccine platforms—requires serum and blood components for cell culture systems. A case study from the vaccine industry indicates that animal blood components are essential raw materials with established regulatory pathways.
4. Raw Material Sourcing and Traceability
Quality and traceability are critical factors in the animal blood & components market. A case study from the regulatory compliance sector indicates that manufacturers with documented supply chains, veterinary oversight, and validated collection and processing protocols capture premium positioning in regulated biopharmaceutical applications.
Exclusive Industry Insights: The Fetal Bovine Serum Dynamics
Our proprietary analysis identifies fetal bovine serum (FBS) as the highest-value and most closely watched segment within the animal blood & components market. FBS is the preferred cell culture supplement due to its high growth factor content and low immunoglobulin levels. However, supply constraints, ethical considerations, and price volatility have driven interest in serum alternatives and defined media. Manufacturers that ensure sustainable sourcing, consistent quality, and supply chain transparency capture competitive advantage in this critical raw material segment.
Strategic Outlook
For industry executives, investors, and marketing leaders evaluating opportunities in the animal blood & components market, the projected 6.7% CAGR reflects sustained demand from biopharmaceutical manufacturing, cell and gene therapy development, and life sciences research. Manufacturers positioned to capture disproportionate share share three characteristics: demonstrated expertise in animal blood collection, processing, and quality control; product portfolios spanning multiple species and component types; and established relationships with biopharmaceutical manufacturers, research institutions, and diagnostic companies. As the market evolves toward defined, animal-free alternatives and enhanced traceability requirements, the ability to deliver consistent, high-quality, and sustainably sourced blood components will define competitive leadership.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
最近の記事
タグ